28/05/12 Questions (Rispondete alle domande che seguono usando il colore rosso per il testo) Tossicologia - Rubbiani Maristella.

Slides:



Advertisements
Similar presentations
CH 11 RISK, TOXICOLOGY and HUMAN HEALTH 21.1 What is Risk? Probability that _______ A.Diff b/n risk assesment and risk managemnt 1.Risk assesment-__ 2.Risk.
Advertisements

Toxicological report Bio 464
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
1 David Loschke18 March 2005 New Zealand Timber Preservation Council Annual Conference 2005 The Australian Pesticides & Veterinary Medicines Authority.
Paracelsus “The dose makes the poison ”. MSDS Environmental Hazards and Human Health Chapter 17.
CONFERENCE ON “ FOOD ADDITIVES : SAFETY IN USE AND CONSUMER CONCERNS“ JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY NAIROBI, 24 JUNE 2014.
Principles of Occupational Toxicology 2 – Types of toxicity
NSF/ANSI STANDARD 61 FRAMEWORK FOR RISK ASSESSMENTS For use by Toxicology Sub-committee only Please do not copy or distribute.
What Do Toxicologists Do?
Toxicology please grab a notes sheet. Toxicology: the study of the adverse effects of chemicals on health. Toxicity: how harmful something is. Depends.
Food Additive Safety The FD&C Act stipulates that food additives be functional and that they must possess a low or insignificant risk to humman health.
APES Get out Ecological Footprint Assignment. Chapter 17 Environmental Hazards & Human Health.
Introduction to Toxicology
REGISTRATION OF FEED ADDITIVES BY SIYABONGA MBAMBO.
Committee on Carcinogenicity (COC) Approach to Risk Assessment of Genotoxic Carcinogens David H. Phillips* COC Chairman Descriptive vs. Quantitative.
Dr. Manfred Wentz Director, Hohenstein Institutes (USA) Head, Oeko-Tex Certification Body (USA) AAFA – Environmental Committee Meeting November 10, 2008.
TRAINING FOR THE HEALTH SECTOR
Examining Bioaccumulation & Biomagnification: Implications for Ecosystems and Human Health.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Key Concepts  Types of hazards people face  Methods of toxicology  Types and measurement of chemical hazards  Types and effects of biological hazards.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 01 - INTRODUCTION.
Chapter 15 Environmental Health, Pollution and Toxicology.
Chapter 15 Environmental Health, Pollution and Toxicology.
TOXICOLOGY Trina Redford, Industrial Hygienist National Naval Medical Center Naval Business Bldg 615, 2 nd Fl. Philadelphia, PA.
Environmental Hazards and Human Health Chapter 17.
Furan in Food Summary and Charge to the FAC and SCNT Terry C. Troxell, Ph.D. Director Office of Plant and Dairy Foods FDA Center for Food Safety and Applied.
Copyright © 2002 University of Maryland School of Nursing. All rights reserved. Comparison of Pharmacology and Toxicology This material was developed at.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 10 – BIOMARKERS Introduction.
Lecture 10 – DNA Mutation Based on Chapter 07 Copyright © 2010 Pearson Education Inc.
Juan Alguacil, MD Huelva University Brussels, 26 June 2012 Limits on Occupational Exposure Limits for Carcinogens 8th Seminar on workers’ protection &
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
Laboratory toxicology. Toxicological methods In vitro –Cell cultures –Cell-free systems –Mechanistic In vivo (lab animals) –Acute –Subchronic –Chronic.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
DNA, Mutations and Hazardous Waste. Prokaryote Cell.
FUNDAMENTALS OF OCCUPATIONAL TOXICOLOGY Vesa Riihimäki, MD, PhD, MSc Finnish Institute of Occupational Health.
Biomarkers and mechanisms of toxicity Course summary 1) Introduction - Overview of toxicity mechanisms (with special respect to environmental contaminants)
Objectives Know radiation and mutagenic chemicals increase the mutation rate and can cause genetic diseases and cancer. Application: Consequences of radiation.
!!!……Molecular Target Concept A gonist Antagonist.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Chapter 17 Environmental Hazards & Human Health
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
Pediatric Subcommittee of the AIDAC October 29-30, Topical Immunosuppressants (Calcineurin Inhibitors) - Animal Toxicology October 30, 2003 Barbara.
『창의적 예측경영』『 효율적 내실경영 』 Toxicity Lee, sang-hwi Chapter 17.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.
USING SCIENCE TO ADDRESS ENVIRONMENTAL PROBLEMS Chapter 2.
Acute Toxicity Studies Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption,
Students type their answers here
Classification. Hazard Classification The GHS is designed to identify and classify the “hazards” of the substances or mixtures, and to communicate those.
Chapter 5 Drug Metabolism
Drug Discovery &Development
METABOLISM / BIOTRANSFORMATION of TOXICANTS.
Green Chemistry Toxicology.
Introduction to Environmental Engineering and Science (3rd ed.)
10 – BIOMARKERS Introduction
THE DOSE MAKES THE POISON
Environmental Toxicology
Food Chemicals Toxicity
Risk, Toxicology, and Human Health Chapter 11
Toxicology.
Risk, Toxicology, and Human Health
Ovanes Mekenyan, Milen Todorov, Ksenia Gerova
What is environmental toxicology ?
Risk, Toxicology, and Human Health
Environmental Health, Pollution and Toxicology
Human and Animal Testing: What’s Appropriate
Presentation transcript:

28/05/12 Questions (Rispondete alle domande che seguono usando il colore rosso per il testo) Tossicologia - Rubbiani Maristella

28/05/12 Give the right sequential order of the following steps. (Number the steps from 1 to 4 on the dots). Risk assessment …… Hazard identification …… Risk management …… Hazard characterisation ……

28/05/12 Indicate what is true about the process of risk evaluation Risk assessment consists of risk characterisation, exposure assessment, risk management and risk communication. Risk assessment integrates hazard characterisation and exposure assessment. Risk management is part of risk assessment. Risk management follows risk assessment.

28/05/12 Indicate what is true about the process of risk evaluation (Indicate all that apply). Risk assessment consists of risk characterisation, exposure assessment, risk management and risk communication. Risk assessment integrates hazard characterisation and exposure assessment. Risk management is part of risk assessment. Exposure assessment follows hazard characterization. Risk management follows risk assessment.

28/05/12 Match each description with its corresponding term. The terms may be used only once. Description Number of Term A. Integrating hazard characteristics with exposure data. …… B. The probability that an adverse effect will occur. …… C. Integrating risk assessment with social, economic and political aspects. …… D. The molecular structure affected by a toxic agent. …… E. A potential danger of a compound or a process. …… Term 1. risk assessment 2. hazard 3. receptor 4. risk 5. risk management

28/05/12 What is true about the process of risk assessment? (Indicate the one best answer). Acute exposure and chronic exposure from a chemical result in effects on a similar target organ, but only at a single high or a repeated low dose of exposure,respectively. DNA can be a toxicological receptor. A dose response curve is important to establish the LD50 which is an important parameter in modern toxicological risk assessment. The LD50 is a constant parameter reflecting the acute toxicity of a chemical for different species.

28/05/12 What is true for ADME characteristics? (Indicate the one best answer). ADME characteristics describe what happens to a compound when it has enteredthe body. ADME characteristics describe the toxicodynamic phase. ADME characteristics determine the bioavailability of a compound upon oral intake. ADME characteristics describe how a compound becomes toxic including the mechanism of action.

28/05/12 What type of biotransformation reactions are phase I reactions? (Indicate the one best answer). N-acetylation, glucuronidation, epoxidation. Hydroxylation, sulfation, glutathione conjugation. Methylation, N-oxidation, nitroreduction. Heteroatom dealkyation, epoxidation, hydroxylation

28/05/12 Fill in the blanks. (Write your answer on the dots). a) The process in which compounds are modified into metabolites that are more toxic than the parent compound is called …………………. b) The most important enzyme system for the phase I biotransformation reactions ………….………

28/05/12 What are important cancer inducing factors? (Indicate all that apply). Environmental contaminants Ionizing radiation Pesticides Food additives Food colours Genetic factors

28/05/12 What is true about mutagenesis? (Indicate all that apply). Mutagenesis consistently predicts carcinogenesis. Mutagenesis can result from oxidative stress. Mutagenesis is a reversible process.

28/05/12 What is true about gene mutations? (Indicate the one best answer). Genetic abnormalities resulting from mutations can be placed in two categories: frameshift mutations and chromosome aberrations. changes in the number of chromosomes, aneuploidy or polyploidy are not considered genetic abnormalities resulting from mutations. Transitions and transversions are frameshift mutations. Most chemical carcinogens with cancer initiating activity are also mutagenic.

28/05/12 What is true about developmental toxicology? (Indicate all that apply). Mutation can be a mechanism underlying teratogenesis. Decreased nutrient supply can be a mechanism underlying teratogenesis. Teratogencity of a chemical is usually reflected by growth retardation at low dose and lethalithy at high dose. The majority of the birth defects are caused by exposure to radiation, drugs,chemicals or maternal metabolic imbalances. Teratogenic agents can have an effect on the placenta only.

28/05/12 What are characteristic toxic effects of chemicals on the skin? (Indicate the one best answer). Contact dermatitis, skin necrosis, skin colourisation. Atopic contact dermatitis, urticaria, phototoxicity. Acne, steatosis, skin cancer. Hydratation, oedema, melanoma.

28/05/12 What is true about endocrine disruption? (Indicate all that apply). Compounds causing endocrine disruption originate from a very narrow class of chemical compounds. Compounds causing endocrine disruption are present in our food and environment. Compounds causing endocrine disruption are toxic to one of the hormone producing organs. Compounds causing endocrine disruption can be a risk factor for cancer incidences.

28/05/12 Match A. Single dose test …… B. 90 days test …… C. 28 days test …… D. Carcinogenicity test …… E. Skin irritation test …… 1. sub-chronic test 2. chronic test 3. acute test 4. short term test 5. specific test

28/05/12 What is true about in vitro testing? (Indicate all that apply). In vitro test alternatives for all in vivo end parameters will be available in the near future. Present in vitro tests can predict the carcinogenic potential of a compound. The Mouse Lymphoma assay can predict both gene mutations as well as several chromosomal adverse effects. In vitro toxicity testing is most useful for genotoxicity and toxicokinetics

28/05/12 The role of safety factors is to take into account… (Indicate all that apply). …differences in life style factors. …differences between species. …differences in methods for exposure assessment. …differences in study designs. …differences in intake levels.